DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

Autor: Luc Fontana, Nadège Rabiau, Nasséra Chalabi, Rémy Bosviel, Samir Satih, Alain Chamoux, Yves-Jean Bignon, Dominique Bernard-Gallon, Laetitia Delort, Fabrice Kwiatkowski
Přispěvatelé: Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Nutrition, Cancérogenèse et Thérapie anti-tumorale, Université d'Auvergne - Clermont-Ferrand I (UdA), Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université, Université Jean Monnet - Saint-Étienne (UJM), Institut de Médecine du Travail, CHU Clermont-Ferrand-Université d'Auvergne - Clermont-Ferrand I (UdA), Qualité des Produits Animaux (QuaPA), Institut National de la Recherche Agronomique (INRA), Laboratoire de Pharmacognosie / Biotechnologies (UMR484)
Rok vydání: 2008
Předmět:
Zdroj: Molecular Cancer, Vol 7, Iss 1, p 36 (2008)
Molecular Cancer
Molecular Cancer, 2008, 7, ⟨10.1186/1476-4598-7-36⟩
ISSN: 1476-4598
DOI: 10.1186/1476-4598-7-36
Popis: Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes,i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damages have been shown to have significantly reduced. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study, 2 functional polymorphisms in a DNA repair geneERCC2were analyzed. The population included 911 breast cancer cases, 51 ovarian cancer cases and 1000 controls. The genotyping of 2 SNP (Single Nucleotide Polymorphism) was carried out on the population with the MGB (Minor Groove Binder) probe technique which consists of the use of the allelic discrimination with the Taqman®method. This study enabled us to show an increase in risk of breast cancer with no oral contraceptive users and with women exhibiting a waist-to-hip ratio (WHR) > 0.85 for Asn homozygous forERCC2 312.
Databáze: OpenAIRE